Identification | Back Directory | [Name]
2-CHLORO-5-FLUOROPYRIMIDIN-4-ONE | [CAS]
155-12-4 | [Synonyms]
2-CHLORO-5-FLUOROPYRIMIDIN-4-ONE 2-Chloro-5-fluoro-pyrimidin-4-ol 2-Chloro-5-fluoro-4-pyrimidinone 2-Chloro-5-fluoro-3H-pyriMidin-4-one 2-Chloro-5-fluoropyriMidin-4(3H)-one 2-chloro-5-fluoro-1H-pyrimidin-6-one 2-Chloro-4-hydroxy-5-fluoropyrimidine 2-Chloro-5-fluoro-1H-pyriMidine-6-one 2-chloro-5-fluoro-4-hydroxypyrimidine 4(3H)-Pyrimidinone, 2-chloro-5-fluoro- 4-(1H)-Pyrimidinone, 2-chloro-5-fluoro- 2-Chloro-5-fluoropyrimidin-4(3H)-one 95+% 4(1H)-Pyrimidinone, 2-chloro-5-fluoro- (9CI) 2-Chloro-3,4-dihydro-5-fluoro-4-oxopyrimidine 2-CHLORO-5-FLUOROPYRIMIDIN-4-ONE ISO 9001:2015 REACH | [Molecular Formula]
C4H2ClFN2O | [MDL Number]
MFCD01346689 | [MOL File]
155-12-4.mol | [Molecular Weight]
148.523 |
Chemical Properties | Back Directory | [Melting point ]
176-177 °C(Solv: ethanol (64-17-5)) | [density ]
1.70±0.1 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [form ]
powder to crystal | [pka]
4.48±0.50(Predicted) | [color ]
White to Light yellow |
Hazard Information | Back Directory | [Synthesis]
The general procedure for the synthesis of 2-chloro-5-fluoropyrimidin-4(3H)-one from 2,4-dichloro-5-fluoropyrimidine was as follows: dimethylaniline (195 mL, 1.54 mol) was added to the slurry formed by 5-fluorouracil (99.73 g, 0.77 mol) and phosphoryl chloride (215 mL, 2.31 mol) under nitrogen protection, and the temperature of the reaction was maintained at 95 °C. The reaction mixture was stirred at this temperature for 3.5 hours and then cooled to room temperature and subsequently slowly poured into a stirred mixture of ice (200 g) and 6 M hydrochloric acid (200 mL). The resulting slurry was extracted with dichloromethane (2 x 400 mL), and the combined organic phases were washed with deionized water (4 x 275 mL), dried over anhydrous magnesium sulfate, and then concentrated under reduced pressure to afford 111.77 g of 5-fluoro-2,4-dichloropyrimidine (87% yield, 98.1% AUC purity as determined by HPLC) as amber oil. Next, 1.34 L of 1 M sodium hydroxide solution was slowly added to a solution of 5-fluoro-2,4-dichloropyrimidine (111.77 g, 0.67 mol) in tetrahydrofuran (377 mL) at 0 °C. The reaction mixture was stirred at room temperature for about 30 min before the pH was slowly adjusted to 6 with 1.0 M hydrochloric acid.The aqueous phase was extracted with ethyl acetate (440 mL) to remove impurities, followed by adjusting the pH to 1 with 1.0 M hydrochloric acid.The acidic aqueous phase was extracted with ethyl acetate (4 x 555 mL).The combined organic phases were washed with brine (111 mL), dried over anhydrous magnesium sulfate, and then concentrated under reduced pressure to give 2- chloro-5-fluoro-3H-pyrimidin-4-one 88.35 g (89% yield, 99% AUC purity by HPLC) as an off-white powder. | [References]
[1] Patent: EP1506967, 2005, A1. Location in patent: Page/Page column 67 [2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 18, p. 4984 - 4995 [3] Patent: US2007/66636, 2007, A1. Location in patent: Page/Page column 19; 20 [4] Journal of Medicinal Chemistry, 2011, vol. 54, # 2, p. 510 - 524 [5] Patent: US2007/60529, 2007, A1. Location in patent: Page/Page column 14 |
|
|